A rating of 45 puts I-Mab ADR (IMAB) near the middle of the Biotechnology industry according to InvestorsObserver. I-Mab ADR's score of 45 means it scores higher than 45% of stocks in the industry. I-Mab ADR also received an overall rating of 46, putting it above 46% of all stocks. Biotechnology is ranked 31 out of the 148 industries.
IMAB has an Overall Score of 46. Find out what this means to you and get the rest of the rankings on IMAB!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 46 means the stock is more attractive than 46 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With I-Mab ADR Stock Today?
I-Mab ADR (IMAB) stock has risen 5.17% while the S&P 500 is down -0.78% as of 11:10 AM on Thursday, Jan 19. IMAB has risen $0.33 from the previous closing price of $6.38 on volume of 236,234 shares. Over the past year the S&P 500 is down -14.00% while IMAB is down -79.51%. IMAB lost -$4.26 per share the over the last 12 months.
Click Here to get the full Stock Report for I-Mab ADR stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
